End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,885 KRW | +0.83% |
|
-1.31% | +7.72% |
2023 | Hancom Lifecare Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2021 | Hancom Lifecare Inc. has completed an IPO in the amount of KRW 113.741798 billion. | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The stock, which is currently worth 2024 to 1028.54 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the past twelve months, EPS forecast has been revised upwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.84% | 96.98M | - | ||
-7.22% | 178B | C+ | ||
-6.72% | 98.53B | C | ||
-7.50% | 65.18B | A | ||
-10.57% | 44.13B | B- | ||
+8.92% | 44.05B | B- | ||
+13.76% | 42.51B | B+ | ||
+9.65% | 28.41B | B | ||
+21.35% | 25.31B | A- | ||
-9.13% | 23.31B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A372910 Stock
- Ratings Hancom Lifecare Inc.